Literature DB >> 15426099

Gold therapy in early rheumatoid arthritis.

C H ADAMS, R L CECIL.   

Abstract

Entities:  

Keywords:  ARTHRITIS, RHEUMATOID; GOLD AND COMPOUNDS

Mesh:

Substances:

Year:  1950        PMID: 15426099     DOI: 10.7326/0003-4819-33-1-163

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  11 in total

1.  Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate.

Authors:  O Sander; G Herborn; E Bock; R Rau
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

2.  GOLD therapy in rheumatoid arthritis. Report of a multicentre control trial.

Authors: 
Journal:  Ann Rheum Dis       Date:  1960-06       Impact factor: 19.103

3.  Observations on gold therapy in rheumatoid arthritis.

Authors:  R A P BROWN; J P CURRIE
Journal:  Br Med J       Date:  1953-04-25

4.  Gold Therapy in Rheumatoid Arthritis.

Authors: 
Journal:  Br Med J       Date:  1962-05-26

5.  Some concepts of rheumatic disease.

Authors:  J H KELLGREN
Journal:  Br Med J       Date:  1952-05-31

6.  Rheumatoid arthritis; the natural history of the disease and its management.

Authors:  C RAGAN
Journal:  Bull N Y Acad Med       Date:  1951-02

7.  HORMONAL TREATMENT OF RHEUMATOID ARTHRITIS.

Authors: 
Journal:  Can Med Assoc J       Date:  1950-12       Impact factor: 8.262

8.  Radiological evaluation of erosions: a quantitative method for assessing long-term remittive therapy in rheumatoid arthritis.

Authors:  W M O'Brien
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

9.  The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis.

Authors:  A Larsen; J Horton; C Howland
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

Review 10.  A clinical and economic review of disease-modifying antirheumatic drugs.

Authors:  S E Gabriel; D Coyle; L W Moreland
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.